A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: A focus on pharmacokinetic variability and pharmacodynamics
Cancer Chemotherapy and Pharmacology Aug 14, 2017
Badowski ME – In this study, oral cannabinoids were targeted for their efficacy, pharmacokinetics (PK), pharmacodynamics (PD), and safety for patients with chemotherapy–induced nausea and vomiting (CINV). Study findings highlighted that a new formulation of oral cannabinoids (i.e., dronabinol oral solution) minimized the PK/PD variability currently observed with capsule formulations.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
